ConductScience.org, home

Paper29326488

Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses.

Hessin AF and 4 others. Indian J Pharmacol, 2017. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses. Papers, record 29326488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29326488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses.
PubMed
Journal
Indian J Pharmacol
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2022-03-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hessin AFAlyaa Farouk
2Hegazy RRRehab Rehab
3Hassan AAAzza Ahmed
4Yassin NZNemat Zakaria
5Kenawy SASanaa Abdel-Baky

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntioxidantsMajor topic
Liver CirrhosisMajor topic
Protein Kinase CMajor topic
StilbenesMajor topic
alpha-FetoproteinsMajor topic
Animals
Male
Oxidative Stress
Rats
Rats, Wistar
Resveratrol

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126159266Hepatic Fibrosis: Emerging Therapies.Dig Dis2015https://conductscience.org/library/papers/26159266PubMed
226530037Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways.Mol Med Rep2016https://conductscience.org/library/papers/26530037PubMed
322626794Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches.Saudi J Gastroenterol2012https://conductscience.org/library/papers/22626794PubMed
414661062Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.Oncogene2004https://conductscience.org/library/papers/14661062PubMed
525974898Resolution of liver fibrosis: basic mechanisms and clinical relevance.Semin Liver Dis2015https://conductscience.org/library/papers/25974898PubMed
613786180The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.Arch Biochem Biophys1961https://conductscience.org/library/papers/13786180PubMed
723997791Mechanism of Hepatoprotective Effect of Boesenbergia rotunda in Thioacetamide-Induced Liver Damage in Rats.Evid Based Complement Alternat Med2013https://conductscience.org/library/papers/23997791PubMed
811172339Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.Hepatology2001https://conductscience.org/library/papers/11172339PubMed
925869468Recent advancement of molecular mechanisms of liver fibrosis.J Hepatobiliary Pancreat Sci2015https://conductscience.org/library/papers/25869468PubMed
1023762157Hepatoprotective Role of Ethanolic Extract of Vitex negundo in Thioacetamide-Induced Liver Fibrosis in Male Rats.Evid Based Complement Alternat Med2013https://conductscience.org/library/papers/23762157PubMed
1125064540Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage.Chem Biol Interact2014https://conductscience.org/library/papers/25064540PubMed
1228959665Anti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male rats.Toxicol Rep2017https://conductscience.org/library/papers/28959665PubMed
1321647311Hepatoprotective Effects of Orthosiphon stamineus Extract on Thioacetamide-Induced Liver Cirrhosis in Rats.Evid Based Complement Alternat Med2011https://conductscience.org/library/papers/21647311PubMed
1423411180Pterostilbene inhibits dimethylnitrosamine-induced liver fibrosis in rats.Food Chem2013https://conductscience.org/library/papers/23411180PubMed
1525311610Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.Nutr Res2014https://conductscience.org/library/papers/25311610PubMed
1622776464Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function.Cell Transplant2012https://conductscience.org/library/papers/22776464PubMed
1710924854Protein kinase C signaling and oxidative stress.Free Radic Biol Med2000https://conductscience.org/library/papers/10924854PubMed
1826742567Resveratrol can prevent CCl₄-induced liver injury by inhibiting Notch signaling pathway.Histol Histopathol2016https://conductscience.org/library/papers/26742567PubMed
1925633908Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.Health Technol Assess2015https://conductscience.org/library/papers/25633908PubMed
2017879097Kinetics of albumin- and alpha-fetoprotein-production during rat liver development.Histochem Cell Biol2007https://conductscience.org/library/papers/17879097PubMed

See all 32 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
41049375The efficacy of resveratrol in the treatment of liver fibrosis: a systematic review and meta-analysis of preclinical studies.Front Nutr2025https://conductscience.org/library/papers/41049375PubMed
38214394Nrf2/HO-1, NF-κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats.J Cell Mol Med2024https://conductscience.org/library/papers/38214394PubMed
38067665Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis.Molecules2023https://conductscience.org/library/papers/38067665PubMed
36825158Protective role of resveratrol against VCM-induced hepatotoxicity in male wistar rats.Front Pharmacol2023https://conductscience.org/library/papers/36825158PubMed
36358524Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis.Antioxidants (Basel)2022https://conductscience.org/library/papers/36358524PubMed
35912113Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications.Front Cell Dev Biol2022https://conductscience.org/library/papers/35912113PubMed
35698613Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis.PeerJ2022https://conductscience.org/library/papers/35698613PubMed
35508992Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth.Mol Med2022https://conductscience.org/library/papers/35508992PubMed
34965258The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats.PLoS One2021https://conductscience.org/library/papers/34965258PubMed
33805795The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials.Nutrients2021https://conductscience.org/library/papers/33805795PubMed
33125088Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA‑20a‑mediated activation of the PTEN/PI3K/AKT signaling pathway.Int J Mol Med2020https://conductscience.org/library/papers/33125088PubMed
33082829A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids.Evid Based Complement Alternat Med2020https://conductscience.org/library/papers/33082829PubMed
32647690Polydatin relieves paraquat-induced human MRC-5 fibroblast injury through inhibiting the activation of the NLRP3 inflammasome.Ann Transl Med2020https://conductscience.org/library/papers/32647690PubMed
32389821Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis.Biomed J2021https://conductscience.org/library/papers/32389821PubMed
29785090Semen Brassicae ameliorates hepatic fibrosis by regulating transforming growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in rats.Drug Des Devel Ther2018https://conductscience.org/library/papers/29785090PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
PRRT2112476PubTator's text mininghttps://conductscience.org/library/genes/112476NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29326488

GET https://conductscience.org/api/papers/v1/29326488/references?page=2